vor 5 Jahren

Merck-Aktie: Neuer Hoffnungsträger gegen Covid-19

Der US-Konzern Merck & Co hat einen Covid-Wirkstoff entwickelt, der Hoffnung macht: In der klinischen Erprobung senkte die Einnahme von Molnupiravir das Risiko einer Krankenhauseinweisung um 50 Prozent. Von Sonja Funke

Quelle: Börse Online RSS Feed

New AI Modvor 4 Stunden
The mathematical flaw of the fiat systemvor 5 Stunden
Sideways Dancevor 6 Stunden
BTC Right now at the momentvor 7 Stunden
My mother is trying to send me Bitcoin from River but they’re blocking it and asking for unclear documentation. Does anyone know what this means?vor 8 Stunden
The BLAKE2b fork is worth understanding as insurance, not as a moonshotvor 8 Stunden
Quantum FUD is for boomers living in Buttcoin. Bitcoin adapts, upgrades and keeps movingvor 10 Stunden
Best personal EUR bank account for frequent incoming and outgoing Binance P2P transfers?vor 11 Stunden
Inherited Bitcoinvor 11 Stunden
Critical Security Exploit in Electrum. Upgrade to version 4.8.3 before signing any transactionsvor 12 Stunden